These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 21493064

  • 21. Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
    Eastwood P, Gonzalez J, Paredes S, Nueda A, Domenech T, Alberti J, Vidal B.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1697-700. PubMed ID: 20137946
    [Abstract] [Full Text] [Related]

  • 22. Pyrimidinyl-substituted amides and thioureas: syntheses, crystal structure and herbicidal activities.
    Liu GH, Xue YN, Lu XQ, Liu MM, Wang WY, Yang LZ.
    Pest Manag Sci; 2008 May 01; 64(5):556-64. PubMed ID: 18080290
    [Abstract] [Full Text] [Related]

  • 23. Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists.
    Yamazaki Y, Abe K, Toma T, Nishikawa M, Ozawa H, Okuda A, Araki T, Oda S, Inoue K, Shibuya K, Staels B, Fruchart JC.
    Bioorg Med Chem Lett; 2007 Aug 15; 17(16):4689-93. PubMed ID: 17553678
    [Abstract] [Full Text] [Related]

  • 24. Pyrazolo[1,5-a]pyrimidines. Identification of the privileged structure and combinatorial synthesis of 3-(hetero)arylpyrazolo[1,5-a]pyrimidine-6-carboxamides.
    Gregg BT, Tymoshenko DO, Razzano DA, Johnson MR.
    J Comb Chem; 2007 Aug 15; 9(3):507-12. PubMed ID: 17439287
    [Abstract] [Full Text] [Related]

  • 25. 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.
    Summa V, Petrocchi A, Matassa VG, Gardelli C, Muraglia E, Rowley M, Paz OG, Laufer R, Monteagudo E, Pace P.
    J Med Chem; 2006 Nov 16; 49(23):6646-9. PubMed ID: 17154493
    [Abstract] [Full Text] [Related]

  • 26. Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: discovery of CCKR1 selectivity in a previously CCKR2-selective lead series.
    Pippel M, Allison BD, Phuong VK, Li L, Morton MF, Prendergast C, Wu X, Shankley NP, Rabinowitz MH.
    Bioorg Med Chem Lett; 2009 Nov 15; 19(22):6373-5. PubMed ID: 19811913
    [Abstract] [Full Text] [Related]

  • 27. New indole amide derivatives as potent CRTH2 receptor antagonists.
    Zaghdane H, Boyd M, Colucci J, Simard D, Berthelette C, Leblanc Y, Wang Z, Houle R, Lévesque JF, Molinaro C, Hamel M, Stocco R, Sawyer N, Sillaots S, Gervais F, Gallant M.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3471-4. PubMed ID: 21515053
    [Abstract] [Full Text] [Related]

  • 28. 2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.
    Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J.
    Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3540-4. PubMed ID: 20483611
    [Abstract] [Full Text] [Related]

  • 29. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
    Yang MG, Xiao Z, Shi Q, Cherney RJ, Tebben AJ, De Lucca GV, Santella JB, Mo R, Cvijic ME, Zhao Q, Barrish JC, Carter PH.
    Bioorg Med Chem Lett; 2012 Feb 01; 22(3):1384-7. PubMed ID: 22225639
    [Abstract] [Full Text] [Related]

  • 30. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
    Zhao H, Xin Z, Patel JR, Nelson LT, Liu B, Szczepankiewicz BG, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL, Liu G.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1825-8. PubMed ID: 15780615
    [Abstract] [Full Text] [Related]

  • 31. Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.
    Sheppeck JE, Gilmore JL, Xiao HY, Dhar TG, Nirschl D, Doweyko AM, Sack JS, Corbett MJ, Malley MF, Gougoutas JZ, Mckay L, Cunningham MD, Habte SF, Dodd JH, Nadler SG, Somerville JE, Barrish JC.
    Bioorg Med Chem Lett; 2013 Oct 01; 23(19):5442-7. PubMed ID: 23953070
    [Abstract] [Full Text] [Related]

  • 32. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I, Alonso-Cires L, López-Tudanca PL, Mosquera R, Labeaga L, Innerárity A, Orjales A.
    J Med Chem; 1999 Jul 29; 42(15):2870-80. PubMed ID: 10425096
    [Abstract] [Full Text] [Related]

  • 33. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor.
    Peschke B, Bak S, Hohlweg R, Nielsen R, Viuff D, Rimvall K.
    Bioorg Med Chem Lett; 2006 Jun 15; 16(12):3162-5. PubMed ID: 16616493
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors.
    Illig CR, Manthey CL, Meegalla SK, Wall MJ, Chen J, Wilson KJ, DesJarlais RL, Ballentine SK, Schubert C, Crysler CS, Chen Y, Molloy CJ, Chaikin MA, Donatelli RR, Yurkow E, Zhou Z, Player MR, Tomczuk BE.
    Bioorg Med Chem Lett; 2013 Dec 01; 23(23):6363-9. PubMed ID: 24138939
    [Abstract] [Full Text] [Related]

  • 35. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K, Miyachi H, Hashimoto Y, Tanatani A.
    Bioorg Med Chem; 2005 Apr 15; 13(8):2837-46. PubMed ID: 15781394
    [Abstract] [Full Text] [Related]

  • 36. 2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers.
    Nikolakopoulos G, Figler H, Linden J, Scammells PJ.
    Bioorg Med Chem; 2006 Apr 01; 14(7):2358-65. PubMed ID: 16314104
    [Abstract] [Full Text] [Related]

  • 37. Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.
    Mahalingam AK, Wan Y, Murugaiah AM, Wallinder C, Wu X, Plouffe B, Botros M, Nyberg F, Hallberg A, Gallo-Payet N, Alterman M.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4570-90. PubMed ID: 20493713
    [Abstract] [Full Text] [Related]

  • 38. Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Wang H, Ruan Z, Li JJ, Simpkins LM, Smirk RA, Wu SC, Hutchins RD, Nirschl DS, Van Kirk K, Cooper CB, Sutton JC, Ma Z, Golla R, Seethala R, Salyan ME, Nayeem A, Krystek SR, Sheriff S, Camac DM, Morin PE, Carpenter B, Robl JA, Zahler R, Gordon DA, Hamann LG.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3168-72. PubMed ID: 18485702
    [Abstract] [Full Text] [Related]

  • 39. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C, Jiang W, Tran JA, Tucci FC, Fleck BA, Markison S, Wen J, Madan A, Hoare SR, Foster AC, Marinkovic D, Chen CW, Arellano M, Saunders J.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):129-36. PubMed ID: 18032040
    [Abstract] [Full Text] [Related]

  • 40. Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.
    Yaziji V, Rodríguez D, Gutiérrez-de-Terán H, Coelho A, Caamaño O, García-Mera X, Brea J, Loza MI, Cadavid MI, Sotelo E.
    J Med Chem; 2011 Jan 27; 54(2):457-71. PubMed ID: 21186795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.